Search

Your search keyword '"Gorgievski, M."' showing total 234 results

Search Constraints

Start Over You searched for: Author "Gorgievski, M." Remove constraint Author: "Gorgievski, M."
234 results on '"Gorgievski, M."'

Search Results

1. Acid mine drainages from copper mines in the southeast Serbia: Local problem with an international impact

2. From job crafting to job quitting?: Testing a wise proactivity perspective

4. Respiratory viruses dynamics and interactions: ten years of surveillance in central Europe

5. Mining for pairs: shared clinic visit dates identify steady HIV‐positive partnerships

6. A highly virulent variant of HIV-1 circulating in the Netherlands

7. Population pharmacokinetic analysis of elvitegravir and cobicistat in HIV-1-infected individuals

8. Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIV-1 subtype B and non-subtype B receiving a salvage regimen

9. Assessing efficacy of different nucleos(t)ide backbones in NNRTI-containing regimens in the Swiss HIV Cohort Study

10. Onkologie

11. Additive effects of HLA alleles and innate immune genes determine viral outcome in HCV infection

12. Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing

15. Private smartphone use during worktime: A diary study on the unexplored costs of integrating the work and family domains

17. Population pharmacokinetic modelling and evaluation of different dosage regimens for darunavir and ritonavir in HIV-infected individuals

18. Ageing with HIV: medication use and risk for potential drug–drug interactions

22. Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIRaben-1 subtype B and non-subtype B receiving a salvage regimen

23. Origin of Minority Drug-Resistant HIV-1 Variants in Primary HIV-1 Infection

24. Clustering of HCV coinfections on HIV phylogeny indicates domestic and sexual transmission of HCV

25. The Interplay Between Host Genetic Variation, Viral Replication, and Microbial Translocation in Untreated HIV-Infected Individuals

26. Ageing with HIV: medication use and risk for potential drug-drug interactions

27. Population pharmacokinetic modelling and evaluation of different dosage regimens for darunavir and ritonavir in HIV-infected individuals

28. Assessing the Paradox Between Transmitted and Acquired HIV Type 1 Drug Resistance Mutations in the Swiss HIV Cohort Study From 1998 to 2012

29. Higher Risk of Incident Hepatitis C Virus Coinfection Among Men Who Have Sex With Men, in Whom the HIV Genetic Bottleneck at Transmission Was Wide

30. Hepatitis B Virus Infection Is Associated With Impaired Immunological Recovery During Antiretroviral Therapy in the Swiss HIV Cohort Study

31. Anti-apolipoprotein A-1 autoantibodies are associated with immunodeficiency and systemic inflammation in HIV patients

32. Assessing efficacy of different nucleos(t)ide backbones in NNRTI-containing regimens in the Swiss HIV Cohort Study

33. Treatment-Naive Individuals Are the Major Source of Transmitted HIV-1 Drug Resistance in Men Who Have Sex With Men in the Swiss HIV Cohort Study

34. Treatment-Naive Individuals Are the Major Source of Transmitted HIV-1 Drug Resistance in Men Who Have Sex With Men in the Swiss HIV Cohort Study

35. Tuberculosis-related mortality in people living with HIV in Europe and Latin America: An international cohort study

36. Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIRaben-1 subtype B and non-subtype B receiving a salvage regimen

37. Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study

39. Increases in Condomless Sex in the Swiss HIV Cohort Study

40. Non-AIDS defining cancers in the D:A:D Study--time trends and predictors of survival: a cohort study

41. Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study

42. Incident Hepatitis C Virus Infections in the Swiss HIV Cohort Study: Changes in Treatment Uptake and Outcomes Between 1991 and 2013

43. Investigation of latent heat of melting and thermal conductivity of the low-melting Bi-Sn-Zn eutectic alloy.

44. Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIRaben-1 subtype B and non-subtype B receiving a salvage regimen

45. Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy : not all AIDS-defining conditions are created equal

46. Obesity Trends and Body Mass Index Changes After Starting Antiretroviral Treatment: The Swiss HIV Cohort Study

47. Development of a definition for rapid progression (RP) of renal function in HIV-positive persons:the D:A:D study

48. Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries

49. Increased risk of cardiovascular disease (CVD) with age in HIV-positive men: a comparison of the D:A:D CVD risk equation and general population CVD risk equations

50. Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries

Catalog

Books, media, physical & digital resources